captopril has been researched along with ceronapril in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 13 (81.25) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badia, MC; Cushman, DW; DeForrest, JM; Dejneka, T; Karanewsky, DS; Loots, MJ; Perri, MG; Petrillo, EW; Powell, JR | 1 |
| Marshall, GR; Waller, CL | 1 |
| Kaneko, K; Osugi, S; Shimamura, K; Sunano, S; Yamamoto, K | 1 |
| Chikugo, T; Morita, N; Ohta, Y; Okamoto, K; Shiokawa, H | 1 |
| Barnes, NM; Costall, B; Egli, P; Horovitz, ZP; Ironside, JW; Naylor, RJ; Williams, TJ | 1 |
| Barnes, NM; Cheng, CH; Costall, B; Naylor, RJ; Williams, TJ; Wischik, CM | 1 |
| DeForrest, JM; Hammerstone, S; Harvey, C; Karanewsky, D; Powell, JR; Scalese, R; Waldron, TL | 1 |
| Chikugo, T; Hamada, Y; Morita, N; Ohta, Y; Okamoto, K; Shiokawa, H | 1 |
| Konishi, C; Ohara, N; Ono, H; Shukunobe, K; Yokota, S | 1 |
| Costall, B; Domeney, AM; Gerrard, PA; Horovitz, ZP; Kelly, ME; Naylor, RJ; Tomkins, DM | 1 |
| Hiwada, K; Inoue, Y; Kokubu, T | 1 |
| Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL | 1 |
| Costall, B; Coughlan, J; Horovitz, ZP; Kelly, ME; Naylor, RJ; Tomkins, DM | 1 |
| Fujishima, M; Ibayashi, S; Nagao, T; Sadoshima, S | 1 |
| Ikeda, M; Kishi, K | 1 |
| Fujii, K; Fujishima, M; Ibayashi, S; Ooboshi, H; Sadoshima, S | 1 |
16 other study(ies) available for captopril and ceronapril
| Article | Year |
|---|---|
(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Indicators and Reagents; Lung; Magnetic Resonance Spectroscopy; Male; Optical Rotation; Organophosphorus Compounds; Proline; Rabbits; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1988 |
Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and com
Topics: Angiotensin-Converting Enzyme Inhibitors; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thermolysin | 1993 |
Effects of chronic treatment with SQ29852 on spontaneous smooth muscle tone and endothelium-dependent relaxation in aorta of stroke-prone spontaneously hypertensive rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Endothelium, Vascular; Hypertension; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1992 |
Chronic treatment with captopril, SQ29,852, hydralazine and a 33% fish meal diet in malignant stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cerebrovascular Disorders; Fish Products; Hydralazine; Hypertension, Malignant; Life Expectancy; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1991 |
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Brain; Captopril; Enalapril; Female; Fosinopril; Humans; Kinetics; Lisinopril; Male; Middle Aged; Organophosphorus Compounds; Proline; Rats; Thiorphan | 1991 |
Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cerebellum; Female; Frontal Lobe; Humans; Male; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Temporal Lobe; Tritium | 1991 |
Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dogs; Female; Hypertension; Hypertension, Renovascular; Lung; Macaca fascicularis; Male; Nephrectomy; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renal Circulation; Species Specificity | 1990 |
Therapy and prevention of hypertension of M-SHRSP.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cerebrovascular Disorders; Diet; Disease Models, Animal; Disease Susceptibility; Fish Flour; Hydralazine; Hypertension, Malignant; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1991 |
Pharmacology of a phosphorus-containing novel angiotensin converting enzyme inhibitor, SQ 29 852 in anesthetized dogs.
Topics: Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Captopril; Dogs; Female; Hemodynamics; Infusions, Intravenous; Male; Organophosphorus Compounds; Proline; Vascular Resistance; Vasodilation | 1991 |
Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anxiety; Behavior, Animal; Callitrichinae; Captopril; Diazepam; Drug Interactions; Female; Male; Mice; Organophosphorus Compounds; Proline; Rats; Species Specificity; Substance Withdrawal Syndrome | 1990 |
Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Enalaprilat; Humans; Kidney; Kinetics; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Protease Inhibitors | 1990 |
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution | 1989 |
The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Captopril; Cognition; Drug Interactions; Habituation, Psychophysiologic; Male; Mice; Organophosphorus Compounds; Proline; Rats; Scopolamine; Time Factors | 1989 |
Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cerebrovascular Circulation; Homeostasis; Hypertension; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1994 |
Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Enalapril; Hypertension, Renovascular; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1993 |
Angiotensin converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain; Captopril; Cerebrovascular Circulation; Female; Ischemic Attack, Transient; Lactates; Organophosphorus Compounds; Parietal Lobe; Proline; Pyruvates; Rats; Rats, Inbred SHR; Regional Blood Flow | 1993 |